Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEALEY ALS Platform Trial - Regimen G DNL343
NCT05842941Phase 3Completed
- Start
- May 2023
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DNL343 in amyotrophic lateral sclerosis (ALS). Started May 2023; status: completed.
02
Drugs
DNL343
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT05842941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05842941.